ALDH1A1 and neoplasm: Similarly, Hwang-Verslues et al. found that the expression of stem cell markers, including CD44+CD24-/low and ALDH1A1, varied between breast cancer cell lines and between primary tumours, and that these markers did not universally enrich for CSCs [9].